Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib (GIDEON)

This study has been completed.
Information provided by:
Bayer Identifier:
First received: December 19, 2008
Last updated: April 17, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
No publications provided by Bayer

Publications automatically indexed to this study by Identifier (NCT Number):